Search

Your search keyword '"A. V. Susekov"' showing total 35 results

Search Constraints

Start Over You searched for: "A. V. Susekov" Remove constraint "A. V. Susekov" Topic business Remove constraint Topic: business
35 results on '"A. V. Susekov"'

Search Results

1. Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG

2. Lipid metabolism disorders and thyrotoxicosis

3. Statins in certain patient populations: scientific evidence and algorithms for practicing physicians

4. Patient with homozygous familial hypercholesterolemia: difficult to treat. Case report

5. The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

6. [Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis]

7. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

8. Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance

9. Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment

10. ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic Epidemiology

11. [Possibilities of clinical use of ezetimibe Otrio (JSC 'AKRIKHIN', Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts]

12. Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?

13. QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY

14. STATINS IN PREVENTION OF ISCHEMIC STROKE

15. Statin therapy and atherosclerosis stabilization in carotid arteries

16. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial

17. [Lipid-Lowering Therapy: a Look Into the Past and Prospects For the Near Future]

18. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

19. Documento oficial de la Sociedad Internacional de Aterosclerosis: recomendaciones generales para el tratamiento de la dislipidemia. Resumen ejecutivo

20. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation

21. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

22. Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)

24. Effect of short-term intensive rosuvastatin therapy on carotid plaque volume in very high cardiovascular risk patients: A three-dimensional ultrasound imaging study

25. Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines

26. Atorvastatin: evidence base 15 years later

27. LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE

28. QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY

29. Familial hypercholesterolaemia: A global call to arms

30. Fat Compartments and Apolipoprotein B-100 Kinetics in Overweight-Obese Men

31. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia

32. Effect of short-term intensive rosuvastatin therapy on carotid atherosclerotic plaque volume in very high cardiovascular risk patients using the three-dimensional ultrasound

33. Clinical Characteristics And LDL-C Achievement Rates In 506 FH Patients From 4 Russian Lipid Clinics

34. MS393 EFFECTS OF EZETIMIBE, INTIAL DOSES OF SATINS, AND ITS COMBINATION ON LIPIDS IN HIGH RISK PATIENTS WITH HYPERLIPIDEAMIA

35. ScreenPro FH - Screening project for familial hypercholesterolemia in central, southern and eastern Europe: Rationale and design

Catalog

Books, media, physical & digital resources